These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 9818622

  • 1. Introduction. Reboxetine: a new selective antidepressant for the treatment of depression.
    Montgomery SA, Schatzberg AF.
    J Clin Psychiatry; 1998; 59 Suppl 14():3. PubMed ID: 9818622
    [No Abstract] [Full Text] [Related]

  • 2. Reboxetine--another new antidepressant.
    Drug Ther Bull; 1998 Nov; 36(11):86-8. PubMed ID: 10562766
    [Abstract] [Full Text] [Related]

  • 3. Antidepressant efficacy and tolerability of the selective norepinephrine reuptake inhibitor reboxetine: a review.
    Burrows GD, Maguire KP, Norman TR.
    J Clin Psychiatry; 1998 Nov; 59 Suppl 14():4-7. PubMed ID: 9818623
    [Abstract] [Full Text] [Related]

  • 4. The role of norepinephrine in the treatment of depression.
    J Clin Psychiatry; 1999 Sep; 60(9):623-31. PubMed ID: 10520985
    [No Abstract] [Full Text] [Related]

  • 5. Novel antidepressant strategies to optimize outcome.
    J Clin Psychiatry; 2000 Sep; 61(9):686-96. PubMed ID: 11030494
    [No Abstract] [Full Text] [Related]

  • 6. Introduction. Norepinephrine: neurotransmitter for the millennium.
    Nemeroff CB.
    J Clin Psychiatry; 2000 Sep; 61 Suppl 10():3-4. PubMed ID: 10910011
    [No Abstract] [Full Text] [Related]

  • 7. Norepinephrine dysfunction in depression.
    Anand A, Charney DS.
    J Clin Psychiatry; 2000 Sep; 61 Suppl 10():16-24. PubMed ID: 10910013
    [Abstract] [Full Text] [Related]

  • 8. Reboxetine: additional benefits to the depressed patient.
    Montgomery SA.
    J Psychopharmacol; 1997 Sep; 11(4 Suppl):S9-15. PubMed ID: 9438228
    [Abstract] [Full Text] [Related]

  • 9. History and evolution of the monoamine hypothesis of depression.
    Hirschfeld RM.
    J Clin Psychiatry; 2000 Sep; 61 Suppl 6():4-6. PubMed ID: 10775017
    [Abstract] [Full Text] [Related]

  • 10. Chairman's overview. The place of reboxetine in antidepressant therapy.
    Montgomery SA.
    J Clin Psychiatry; 1998 Sep; 59 Suppl 14():26-9. PubMed ID: 9818628
    [Abstract] [Full Text] [Related]

  • 11. New antidepressant drug opens up important treatment and safety options.
    Ir Med J; 1996 Sep; 89(6):214. PubMed ID: 9011559
    [No Abstract] [Full Text] [Related]

  • 12. The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.
    Hajós M, Fleishaker JC, Filipiak-Reisner JK, Brown MT, Wong EH.
    CNS Drug Rev; 2004 Sep; 10(1):23-44. PubMed ID: 14978512
    [Abstract] [Full Text] [Related]

  • 13. Use of reboxetine in bulimia nervosa: a pilot study.
    Fassino S, Daga GA, Boggio S, Garzaro L, Pierò A.
    J Psychopharmacol; 2004 Sep; 18(3):423-8. PubMed ID: 15358988
    [Abstract] [Full Text] [Related]

  • 14. [Depressed, lacking motivation, unconcentrated. Signs of central deficiency of noradrenaline].
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):56. PubMed ID: 15526675
    [No Abstract] [Full Text] [Related]

  • 15. Reboxetine treatment of depression in Parkinson's disease.
    Lemke MR.
    J Clin Psychiatry; 2000 Nov 08; 61(11):872. PubMed ID: 11105742
    [No Abstract] [Full Text] [Related]

  • 16. The effects of antidepressants on psychomotor function with particular reference to reboxetine.
    Hindmarch I.
    Eur Neuropsychopharmacol; 1997 Apr 08; 7 Suppl 1():S17-21; discussion S71-3. PubMed ID: 9169307
    [Abstract] [Full Text] [Related]

  • 17. Reboxetine for the treatment of patients with Cocaine Dependence Disorder.
    Szerman N, Peris L, Mesías B, Colis P, Rosa J, Prieto A, Grupo de Estudio del Uso de Reboxetina en Dependencia a Cocaina.
    Hum Psychopharmacol; 2005 Apr 08; 20(3):189-92. PubMed ID: 15799010
    [Abstract] [Full Text] [Related]

  • 18. Monoamine dysfunction and the pathophysiology and treatment of depression.
    Charney DS.
    J Clin Psychiatry; 1998 Apr 08; 59 Suppl 14():11-4. PubMed ID: 9818625
    [Abstract] [Full Text] [Related]

  • 19. Noradrenaline in basic models of depression.
    Leonard BE.
    Eur Neuropsychopharmacol; 1997 Apr 08; 7 Suppl 1():S11-6; discussion S71-3. PubMed ID: 9169306
    [Abstract] [Full Text] [Related]

  • 20. Rapid improvement in affective information processing after acute administration of reboxetine.
    Thase ME.
    Am J Psychiatry; 2009 Oct 08; 166(10):1096-9. PubMed ID: 19797440
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.